Compensatory recovery of blood glucose levels in KKAy Mice Fed a High-Fat Diet: Insulin-sparing effects of PACAP overexpression in β cells

Journal of Molecular Neuroscience

Volumn 48, Issue 3, 2012, Pages 647-653

  Sakurai, Yusuke ^a,b   Inoue, Hiroaki ^a   Shintani, Norihito ^a   Arimori, Akihiro ^a   Hamagami, Ken Ichi ^a   Hayata Takano, Atsuko ^a   Baba, Akemichi ^c   Hashimoto, Hitoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

cells; High fat diet; KKAy mice; Pituitary adenylate cyclase activating polypeptide; Type 2 diabetes

Indexed keywords

GLUCOSE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INSULIN; NEUROPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID DIET; LIPID STORAGE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; PROTEIN EXPRESSION;

AGOUTI SIGNALING PROTEIN; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CROSSES, GENETIC; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENERGY INTAKE; GENE EXPRESSION; HYPERINSULINISM; HYPERPHAGIA; HYPERPLASIA; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; ISLETS OF LANGERHANS; LIVER; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OBESITY; ORGAN SIZE; PANCREAS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECOMBINANT FUSION PROTEINS;

ANIMALIA; MUS;

EID: 84868205307     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-012-9758-9     Document Type: Article

References (32)

1. Adams BA, Gray SL, Isaac ER, Bianco AC, Vidal-Puig AJ, Sherwood NM (2008) Feeding and metabolism in mice lacking pituitary adenylate cyclase-activating polypeptide. Endocrinology 149 (4):1571-1580 (Pubitemid 351468343)
2. Ahrén B (2008) Role of pituitary adenylate cyclase-activating polypeptide in the pancreatic endocrine system. Ann N Y Acad Sci 1144:28-35
3. Ahrén B, Pacini G (2002) Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice. Am J Physiol Endocrinol Metab 283(4):E738-744
4. Andreasen CH, Andersen G (2009) Gene-environment interactions and obesity - further aspects of genomewide association studies. Nutrition 25(10):998-1003
5. Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B (2002) Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab 282 (4):E834-842 (Pubitemid 34654745)
6. Cefalu WT (2006) Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition. ILAR J 47(3):186-198 (Pubitemid 43986028)
7. Dalle S, RavierMA, BertrandG (2011) Emerging roles for β-arrestin-1 in the control of the pancreatic β-cell function and mass: new therapeutic strategies and consequences for drug screening. Cell Signal 23(3):522-528
8. Green BD, Irwin N, Cassidy RS, Gault VA, Flatt PR (2006) Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice. Peptides 27(9):2343-2349 (Pubitemid 44189634)
9. Haba R, Shintani N, Onaka Y et al (2012) Lipopolysaccharide affects exploratory behaviors toward novel objects by impairing cognition and/or motivation in mice: possible role of activation of the central amygdala. Behav Brain Res 228(2):423-431
10. Hamagami K, Sakurai Y, Shintani N et al (2009) Over-expression of pancreatic pituitary adenylate cyclase-activating polypeptide (PACAP) aggravates cerulein-induced acute pancreatitis in mice. J Pharmacol Sci 110(4):451-458
11. Iwatsuka H, Shino A, Suzuoki Z (1970) General survey of diabetic features of yellow KK mice. Endocrinol Jpn 17(1):23-35
12. Nakata M, Yada T (2007) PACAP in the glucose and energy homeostasis: physiological role and therapeutic potential. Curr Pharm Des 13(11):1105-1112 (Pubitemid 46739340)
13. Nakata M, Kohno D, Shintani N et al (2004) PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPYcontaining neurons in the rat hypothalamic arcuate nucleus. Neurosci Lett 370(2-3):252-256 (Pubitemid 39370889)
14. Parekh PI, Petro AE, Tiller JM, Feinglos MN, Surwit RS (1998) Reversal of diet-induced obesity and diabetes in C57BL/6J mice. Metabolism 47(9):1089-1096 (Pubitemid 28428014)
15. Romao I, Roth J (2008) Genetic and environmental interactions in obesity and type 2 diabetes. J Am Diet Assoc 108(4 Suppl 1): S24-28 (Pubitemid 351389300)
16. Sakurai Y, Shintani N, Hayata A, Hashimoto H, Baba A (2011) Trophic effects of PACAP on pancreatic islets: a mini-review. J Mol Neurosci 43(1):3-7
17. Samuel VT, Liu ZX, Qu X et al (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279 (31):32345-32353 (Pubitemid 39014687)
18. Shino A, Iwatsuka H (1970) Morphological observations on pancreatic islets of spontaneous diabetic mice, "Yellow KK". Endocrinol Jpn 17(6):459-476
19. Shintani N, Tomimoto S, Hashimoto H, Kawaguchi C, Baba A (2003) Functional roles of the neuropeptide PACAP in brain and pancreas. Life Sci 74(2-3):337-343 (Pubitemid 37361078)
20. Smith BK, Andrews PK, West DB (2000) Macronutrient diet selection in thirteen mouse strains. Am J Physiol Regul Integr Comp Physiol 278(4):R797-805 (Pubitemid 30215190)
21. Sohda T, Kawamatsu Y, Fujita T, Meguro K, Ikeda H (2002) Discovery and development of a new insulin sensitizing agent, pioglitazone. Yakugaku Zasshi 122(11):909-918 (Pubitemid 41320966)
22. Srinivasan K, Ramarao P (2007) Animal models in type 2 diabetes research: an overview. Indian J Med Res 125(3):451-472 (Pubitemid 46805458)
23. Tomimoto S, Hashimoto H, Shintani N et al (2004) Overexpression of pituitary adenylate cyclase-activating polypeptide in islets inhibits hyperinsulinemia and islet hyperplasia in agouti yellow mice. J Pharmacol Exp Ther 309(2):796-803 (Pubitemid 38542636)
24. Tomimoto S, Ojika T, Shintani N et al (2008) Markedly reduced white adipose tissue and increased insulin sensitivity in adcyap1- deficient mice. J Pharmacol Sci 107(1):41-48 (Pubitemid 351760826)
25. Tsunekawa S, Miura Y, Yamamoto N et al (2005) Systemic administration of pituitary adenylate cyclase-activating polypeptide maintains beta-cell mass and retards onset of hyperglycaemia in betacell- specific calmodulin-overexpressing transgenic mice. Eur J Endocrinol 152(5):805-811 (Pubitemid 40744549)
26. Vaudry D, Falluel-Morel A, Bourgault S et al (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61(3):283-357
27. Weinstock RS, Murray FT, Diani A, Sangani GA, Wachowski MB, Messina JL (1997) Pioglitazone: in vitro effects on rat hepatoma cells and in vivo liver hypertrophy in KKAy mice. Pharmacology 54(4):169-178 (Pubitemid 27234720)
28. Winzell MS, Ahrén B (2004) The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53(Suppl 3):S215-219 (Pubitemid 39564546)
29. Yada T, Sakurada M, Ihida K et al (1994) Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J Biol Chem 269(2):1290-1293 (Pubitemid 24032521)
30. Yada T, Sakurada M, Filipsson K, Kikuchi M, Ahrén B (2000) Intraperitoneal PACAP administration decreases blood glucose in GK rats, and in normal and high fat dietmice. Ann N YAcad Sci 921:259-263 (Pubitemid 32094551)
31. Yamamoto K, Hashimoto H, Tomimoto S et al (2003) Overexpression of PACAP in transgenic mouse pancreatic beta-cells enhances insulin secretion and ameliorates streptozotocin-induced diabetes. Diabetes 52(5):1155-1162 (Pubitemid 36523350)
32. Yu R, Yi T, Xie S, Hong A (2008) Long-term administration of maxadilan improves glucose tolerance and insulin sensitivity in mice. Peptides 29(8):1347-1353